#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute myeloid leukaemia (in remission) B-cell lymphoma Emphysema Wolfram syndrome Myelofibrosis Thrombotic thrombocytopenic purpura Anaplastic large cell lymphoma T- and null-cell types Blastic plasmacytoid dendritic cell neoplasia Neonatal asphyxia Multiple system atrophy Prolymphocytic leukaemia Transferrin decreased Guillain-Barre syndrome Acute graft versus host disease in intestine Antiphospholipid syndrome More trials…

    Learn about Rare Diseases

    Bronchiolitis obliterans syndrome – Life with Disease Antithrombin III deficiency – Treatment Encephalitis autoimmune – Life with Disease Idiopathic pulmonary fibrosis Chondrosarcoma metastatic – Basic Information Haemophagocytic lymphohistiocytosis – Diagnostics Primary biliary cholangitis – Treatment Alport’s syndrome – Diagnostics Friedreich’s ataxia – Diagnostics Alexander disease – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gsk6097608 Sibeprenlimab Rineterkib Eculizumab Amantadine Hydrochloride Cobamamide Diphenhydramine Hydrochloride Pancreas Powder INSULIN DETEMIR Pemigatinib Potassium Digoxin Immune Fab (Ovine) Pegaspargase Fedratinib Natalizumab Lidocaine Hydrochloride Immunoglobulin M Tub-040 Prax-628 Resmetirom More therapies…

    Learn about Your Condition

    Abdominal infection Fibrous dysplasia of bone Venous thrombosis Thrombectomy Type 1 diabetes mellitus Fallopian tube cancer stage IV Kaposi's sarcoma Follicular lymphoma Toxic nodular goitre Lichen planus Diarrhoea Gestational diabetes Hairy cell leukaemia recurrent Rectal adenocarcinoma HER2 negative breast cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Metabolism

  • Study on the Effects of Ertugliflozin and Semaglutide on Heart Health in Patients with Type 2 Diabetes

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Canagliflozin
    • Ertugliflozin
    • Insulin Aspart
    Italy

  • Study of Long-Term Neurocognitive Outcomes in Children with Phenylketonuria Treated with Sepiapterin

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Phenylketonuria
    Investigated Drugs:
    • Sepiapterin
    France Ireland Poland Sweden

  • Study on Oxytocin Nasal Spray for Patients with Central Diabetes Insipidus

    Recruiting

    2 1 1
    Investigated Diseases:
    • Diabetes insipidus
    Germany The Netherlands

  • Study on Sotagliflozin for Slowing Kidney Disease in Type 1 Diabetes Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Sotagliflozin
    Denmark

  • A Study of Vildagliptin to Prevent Diabetes in Kidney Transplant Recipients During Early Post-Transplant Period

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Vildagliptin
    France

  • Study on Semaglutide for Weight Loss in Patients with HIV and Obesity

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • HIV infection
    • Obesity
    Investigated Drugs:
    • Semaglutide
    Denmark Ireland Italy
1 2 3 … 7
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!